Evidence map›Paper›PMID 42353010›Full record

ArticleInternational journal of molecular sciences2026

Exploring Dystrophin Expression and Mutations in the

Juliana Salazar, Paula Cerdà, Alícia Artigas, Ruth Orellana, Allan González, Raúl Terés, María J Arranz, Silvia Bagué, Caterina Fumagalli, José Antonio González and 6 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Juliana SalazarTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0002-3581-4499
Paula CerdàTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-0101-188X
Alícia ArtigasInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-0486-268X
Ruth OrellanaInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-1260-7064
Allan GonzálezInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
Raúl TerésTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
María J ArranzResearch Laboratory Unit, Fundació Docència i Recerca Mútua Terrassa, 08221 Terrassa, Spain.ORCID 0000-0002-6757-9198
Silvia BaguéInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0001-9980-7231
Caterina FumagalliInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
José Antonio GonzálezGeneral Surgery Unit, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.ORCID 0000-0001-8630-1952
Ana PeiróDepartment of Orthopedic and Traumatology Surgery, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.ORCID 0009-0002-9806-0695
Lidia González-QueredaInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-0715-6414
María José RodríguezInstitut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
Eduard GallardoU762 CIBERER (Rare Diseases Network Research Centre), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0002-3942-3436
María AguadoTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.
Ana SebioTranslational Medical Oncology Laboratory, Institut de Recerca Sant Pau (IR Sant Pau), 08041 Barcelona, Spain.ORCID 0000-0003-3333-2370

Funding

Institute of Health Carlos III PI17/000143
6 · The paper itself

Abstract

Molecular factors influencing prognosis in leiomyosarcomas (LMS) remain poorly understood. Given that LMS arise from smooth muscle and that the dystrophin gene (

Indexed as

DystrophinLeiomyosarcomaMutationAdultAgedBiomarkers, TumorFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesBiomarkers, TumorDystrophinbiomarkerdystrophindystrophin–glycoprotein complexleiomyosarcomasprognosis

Identifiers

PMID42353010
PMCPMC13299629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.